Success Stories: An Indian Research Scientist II is Nearing Green Card Success After Receiving Two Approvals for I-140 Petition (NIW + EB1A)
Client’s Testimonial:
“Both Chen group and my Attorney W.B. did an amazing job for my EB1-A and NIW petitions. Thank you so much for your immense patience in editing my petition so many times!”
On June 7th, 2023 and February 9th, 2024, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) Approval for a Research Scientist II in the Field of Medicinal Chemistry (Approval Notice).
General Field: Medicinal Chemistry
Position at the Time of Case Filing: Research Scientist II
Country of Origin: India
Approval Notice Date: June 7th, 2023 (NIW) and February 9th, 2024 (EB1A)
Processing Time: 2 days (NIW) (Premium Processing Requested) and 7 days (EB1A) (Premium Processing Requested)
Case Summary:
When a research scientist II from India hired us to help him compile an EB-2 NIW (National Interest Waiver) petition, we began to peruse his documents package. He is one of the few leading experts in designing, synthesizing, and discovering drug-like small molecules and peptides within the medicinal chemistry field, and he has achieved a consistent and notable record of success and influence in these areas of study.
We deduced that his research addresses some of our nation’s most pressing issues, including antimicrobial resistance and antibiotic discovery, and treating Alzheimer’s disease. Thus, our objective became to persuade USCIS that our client’s research is dedicated to researching and developing new chemical synthesis methods for novel therapeutic agents while researching and implementing medicinal chemical strategies for developing novel antimicrobial therapeutic agent-discovery programs
After we sent the USCIS his NIW case presentation, he eventually made the decision to hire our legal team to assist him in filing a second petition under the EB-1A (Alien of Extraordinary Ability) visa category, increasing his chances of receiving a green card without encountering any more obstacles. A significant step toward receiving their green cards is taken by the numerous petitioners who file multiple petitions.
We listed his achievements from his doctor of philosophy in medicinal chemistry to showcasing his extraordinary record of 26 peer-reviewed scientific articles in journals and conferences he published, gathering 516 citations. These citations come from internationally leading researchers from well-regarded institutions and organizations from at least 41 countries, indicating the influential importance of his work. A number of his publications have also been cited at a much higher rate than those of other researchers in the field. Besides, he has also completed 102 peer reviews, exhibiting how his achievements are of the utmost importance due to their direct applicability in global efforts and the advancement of fundamental physics.
Moreover, we detailed that his work has also been granted financial support from the National Institute of General Medical Sciences (NIGMS), the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the Science Education and Engineering Board (SERB, India), the Council of Scientific & Industrial Research (CSIR, India), and the Department of Biotechnology (DBT, India. This support of his research therefore serves as evidence that it is crucial for progressing disease treatment and improving quality of life and public health.
Finally, we incorporated four recommendation letters obtained by other noteworthy experts in the field, testifying that he is a vital asset to the United States and there is little doubt that he operates at the top of his field. The recommendation excerpt below was taken from one of the letters that was submitted:
“It is evident from [client's] body of original research that he is an exceptional member of the field. His research, including his work on novel techniques for amino acid and peptide synthesis and the discovery of novel antimicrobial agents, has direct implications for the healthcare sector of the U.S. and for millions of Americans who are suffering from various diseases. Therefore, he is an essential member of the nation's research community and his endeavors must be sustained.”
Evidently, our client's expertise has consistently filled gaps in the current knowledge of medicinal chemistry, benefiting the pharmaceutical and biomedical industries. As a result, he has established himself as a key researcher within the United States. We are glad that our client secured his NIW approval within two days of the case submission, saving him from having to wait months. Similarly, his EB1A approval came about just one week after we filed his case, all because of USCIS's premium processing service upgrade applied to both cases. We sincerely thank our client for choosing us to represent his I-140 applications and wish him the best of luck in all his future endeavors.